2008
DOI: 10.1097/pdm.0b013e31816184c6
|View full text |Cite
|
Sign up to set email alerts
|

Keratin-positive Gastrointestinal Stromal Tumor of the Stomach Mimicking Gastric Carcinoma: Diagnosis Confirmed by c-kit Mutation Analysis

Abstract: In routine practice, gastrointestinal stromal tumor (GIST) can usually be identified with relative ease on the basis of a rather simple immunohistochemical panel besides its characteristic morphology. Still, serious differential diagnostic problems may arise because of the heterogeneity of these tumors in both morphologic appearance and clinical behavior. In our case, we present a metastatic, ulcerative, hemorrhagic GIST with epithelioid appearance, which displayed diffuse pan cytokeratin (AE1/AE3) positivity … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
11
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 14 publications
(11 reference statements)
0
11
0
Order By: Relevance
“…The fact that GISTs may demonstrate focal EMA immunopositivity is consistent with these neoplasms potentially showing expression of other epithelial markers, e.g. cytokeratins 9–12 . GISTs may demonstrate CD99 immunopositivity, 8 whereas synovial sarcoma can show both CD117 and DOG1 immunopositivity 4,5 .…”
Section: Discussionmentioning
confidence: 62%
See 1 more Smart Citation
“…The fact that GISTs may demonstrate focal EMA immunopositivity is consistent with these neoplasms potentially showing expression of other epithelial markers, e.g. cytokeratins 9–12 . GISTs may demonstrate CD99 immunopositivity, 8 whereas synovial sarcoma can show both CD117 and DOG1 immunopositivity 4,5 .…”
Section: Discussionmentioning
confidence: 62%
“…Immunohistochemical markers, which are often expressed by synovial sarcomas, include CD99, epithelial membrane antigen (EMA) and cytokeratins 7 . It is well documented that GISTs can express CD99 8 and/or cytokeratins (cytokeratin cocktails or specific cytokeratin subtypes) 9–12 . By contrast, while there have been a few case reports of GISTs being found to be EMA immunonegative, 10,11,13 we are unaware of any formal studies of whether this neoplasm can express EMA.…”
Section: Introductionmentioning
confidence: 93%
“…If spindle-cell components or epithelioid cells with unusual morphology and immunophenotype are present, other potential diagnoses should be considered, and additional ancillary tests are needed to make an accurate diagnosis. Several reports have demonstrated that GIST may have CK-positivity with variable intensities and patterns[2-6]. CK expression in GIST using monoclonal CK antibodies, such as CK18 or CK8, has been evaluated in several studies, and these studies support the conclusion that CK-immunoreactivity is more frequently noted in the epithelioid area than in the spindle-cell area (Table 1).…”
Section: Discussionmentioning
confidence: 76%
“…A definitive diagnosis of GIST is important to ensure administration of effective drugs, such as imatinib mesylate, and immmunohistochemical staining for c-Kit or DOG1 is useful for the diagnosis. According to previous studies, cytokeratin (CK) expression is a rare event in GISTs[2-6], so they can easily be misdiagnosed as other epithelial or epithelioid mesenchymal tumors. In such cases, a diagnosis of GIST can be made when DOG1 immunoreactivity or mutation of KIT or PDGFRA are observed.…”
mentioning
confidence: 99%
“…DOG1 was highly specific for GIST, but exceptional DOG1-positive other mesenchymal tumors were found [15]. Further, keratin-positive GIST should also be considered as GIST can be positive for both KIT and cytokeratin [16]. In these cases, c-kit mutation analysis can be helpful.…”
Section: Introductionmentioning
confidence: 98%